Financial statements Green-Bio-Technology
Balance sheet data of GREEN-BIO-TECHNOLOGY
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 805 629,95 | 495 991,72 | 405 880,94 | 326 947,99 |
| A. Fixed assets | 0,00 | 357 120,00 | 361 518,40 | 277 414,91 |
| B. Current assets | 802 629,95 | 138 056,72 | 43 547,54 | 48 718,08 |
| C. Share capital contributions (basic funds) | 3 000,00 | 815,00 | 815,00 | 815,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 805 629,95 | 495 991,72 | 405 880,94 | 326 947,99 |
| A. Equity | 778 919,59 | 485 304,44 | 389 149,74 | 308 790,65 |
| B. Liabilities and provisions for liabilities | 26 710,36 | 10 687,28 | 16 731,20 | 18 157,34 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 26 710,36 | 10 687,28 | 16 731,20 | 18 157,34 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.